Overview

Buprenorphine for Treatment Resistant Depression

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and efficacy of buprenorphine with placebo for adults with treatment resistant depression (TRD).
Phase:
Phase 3
Details
Lead Sponsor:
University of Pittsburgh
Collaborator:
National Alliance for Research on Schizophrenia and Depression
Treatments:
Buprenorphine